Log In | Register
Drug giant AstraZeneca attempted to obscure the connection between one of its blockbuster drugs and diabetes risk for years after it knew of the problem, according to documents recently unsealed as part of lawsuits against the company.
AstraZeneca Denied Seroquels Link to Diabetes for Years After Admitting Link to Japanese Physicians
Seeded on Thu Jun 17, 2010 12:37 PM EDT
Article Source: Gulf human rights hero Thomas B. Manton falsely imprisoned, murdered- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
"It's pretty clear that if a drug poses a diabetes risk in one country, it poses that risk in others," said psychiatrist Dan Carlat of Tufts University. "I don't think it's ethical to warn doctors in Japan about this drug and then downplay or ignore the risk in the U.S."
'Other documents reveal that the company trained its salespeople to dodge questions about the connection between Seroquel and weight gain.'
'Seroquel remains AstraZeneca's second-best selling drug, pulling in $4.45 billion in 2008.'
- 1 vote
#1 - Thu Jun 17, 2010 12:38 PM EDTYou're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.
